Global deal to provide COVID antibody test tech free to poorer countries
A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and low-income countries
Stay updated with breaking news from Technology Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and low-income countries
WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalized a licensing agreement with the Spanish National
The existing four tests, which check for the presence of SARS-CoV-2 antibodies developed after either an infection or a vaccine dose, could also inform decisions on the need for boosters to protect against the disease.
WHO's COVID-19 Technology Access Pool and the Medicines Patent Pool today finalized a licensing agreement with the Spanish National Research Council for a COVID-19 serological antibody technology.
According to the latest figures from Joint United Nations Programme on AIDS (UNAIDS), underinvestment in the Human Immuno-deficiency Virus (HIV) responses of low- and middle-income countries